Active BE 0803.514.247Private limited company

Xper Research

Keirestraat 14 ·9700 Oudenaarde, Belgium· 3 yrs active

Sector: Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg (74999)

Conclusion Checked

The computed 12-month bankruptcy probability of Xper Research is 0.6% (low). The 2025 annual accounts show equity of €462k and a net result of €276k. Its solvency ranks better than 41% of 43 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Key figures

Equity	€462k
Net result	€276k
Staff (FTE)	9.7
Better than sector	41%

Snowflake analysis 5 of 5 axes measured · computed by Checked

90 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 94

Profitability 100

Solvency 84

Growth 78

Stability 94

Bankruptcy probability (12 mo) Checked model v1 · free

0.6% Low

0%0,5%1,5%4%10%≥25%

Young company +Lower-failure-rate sector −Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

0 / 100

Low risk

Trust signals 2 signals

More than 3 years active

Founded in 2023, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags 0 events

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Health barometer FY 2025 · computed

94 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Financial overview2 NBB filings

Annual accounts filed on 27-04-2026 with the NBB · fiscal year 2025 · verkort

Operating resultNet result

Sector comparison

Fiscal year 2025 · NACE 74 · compared within the same schema type (abbreviated schema)

Metric	This company	Sector median	Position in the sector
Solvency	41.7%	47.1%	better than 41% of 43 sector peers
Net result	€276k	€27k	better than 95% of 43 sector peers
Equity	€462k	€92k	better than 85% of 43 sector peers
Gross operating margin	€1.25M	€64k	better than 95% of 43 sector peers
Total assets	€1.11M	€226k	better than 79% of 43 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€395k

+59.6% 24-25

Net profit

€276k

+50.3% 24-25

Cash flow

€286k

+52.2% 24-25

Total assets

€1.11M

+182.1% 24-25

Equity

€462k

+147.9% 24-25

Working capital

€513k

+204.2% 24-25

Employees (FTE)

10

+177.1% 24-25

Staff costs

€856k

+204.4% 24-25

Income taxes

€97k

+68.9% 24-25

Debt

€647k

+213.0% 24-25

Debt ≤ 1y

€550k

+166.9% 24-25

Current ratio

1.93

+6.3% 24-25

Quick ratio

1.93

+6.3% 24-25

Solvency

41.7%

-12.1% 24-25

Debt / equity

1.40

+26.3% 24-25

ROE

59.7%

-39.4% 24-25

ROA

24.9%

-46.7% 24-25

Interest coverage

32.48

-74.2% 24-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	verkort
Revenue	-
EBITDA	€395k
Net profit	€276k
Cash flow	€286k
Staff costs	€856k
Income taxes	€97k
Dividends	-
Total assets	€1.11M
Equity	€462k
Debt	€647k
of which ≤ 1y	€550k
of which > 1y	-
Working capital	€513k
Employees (FTE)	9.7

Ratios (computed)

	2025
Current ratio	1.93
Quick ratio	1.93
Working capital ratio	46.2%
Solvency	41.7%
Debt / equity	1.40
Long-term debt ratio	-
Interest coverage	32.48
Gross margin	-
Net margin	-
ROA	24.9%
ROE	59.7%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €46k · 4.2% Current assets €1.06M · 95.8%

Equity & liabilities

Equity €462k · 41.7% Debt €647k · 58.3%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.11M
Fixed assets	21/28	€46k
Tangible fixed assets	22/27	€33k
Financial fixed assets	28	€13k
Current assets	29/58	€1.06M
Amounts receivable within one year	40/41	€703k
Cash & bank	54/58	€333k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.11M
Equity	10/15	€462k
Contributions / capital	10/11	€3k
Reserves	13	€459k
Amounts payable	17/49	€647k
Amounts payable within one year	42/48	€550k
Trade debts payable within one year	44	€260k
Income statement
Gross operating margin	9900	€1.25M
Operating result	9901	€385k
Financial income	75	€231
Financial charges	65	€12k
Result before taxes	9903	€373k
Income taxes	67/77	€97k
Net result for the period	9904	€276k
Result to be appropriated	9905	€276k

You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →

Ratios computed by Checked.

Legal Structure

NACE primary	Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg(74999)
Legal form	Private limited company(610)
Incorporation	03-07-2023
Status	Active
Postal code	9700

Connections & network 1 connected companies

Group structure

Lorentis

We sit on their board

→

Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Ownership & control 1 parties

Xper ResearchBE 0803.514.247

controls

Where this company holds controlthis company sits on their board1

Lorentis

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Establishment units 1 location

Xper Research

Keirestraat 14, 9700 OudenaardeOverige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

since 20232.347.176.603

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
45021A1116/00D000	Flanders	1,808 m²	1 · 151 m²	8.2 m · 2 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 3 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026

27-04-2026

NBB filing Annual accounts filed

fiscal year 2025 · verkort

2025

11-09-2025

State Gazette act Director changes

18-06-2025

NBB filing Annual accounts filed

fiscal year 2024 · micro

Belgisch Staatsblad, acts 1 acts

All acts · 1 updated 11 months ago

2025

11-09-2025 4 directors appointed Director changes

Jan Eelen, Vaste vertegenwoordiger
Magdaleen Pieters, Vaste vertegenwoordiger
Christof Debèfve, Vaste vertegenwoordiger
Het Ondernemershuis BV

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "board_snapshot",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Jan Eelen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Eelen Clinical Consulting BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2025-04-01",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Magdaleen Pieters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Pieters Clinical Consulting BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2025-04-01",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "vaste_vertegenwoordiger",
      "person": {
        "rrn": null,
        "name": "Christof Deb\u00E8fve",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "FICC BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": "niet_statutair",
      "compensated": false,
      "effective_date": "2025-04-01",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": null,
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": "0783.344.779",
        "name": "Het Ondernemershuis BV",
        "address": "Kessel-Dorp 22, 2560 Kessel",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "publication_proxy",
      "role": null,
      "person": {
        "rrn": null,
        "name": "Rein Dillen",
        "address": null,
        "birth_date": null,
        "profession": "bestuurder",
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Kastell BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-09-11",
    "filing_date": null,
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "bijzondere_algemene_vergadering",
      "date": "2025-04-01",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0803.514.247",
    "name_full": "Xper Research",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Kastell BV",
    "person_name": null,
    "org_rep_person_name": "Rein Dillen",
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "de notulen van de bestuursvergadering d.d. 01/04/2025"
  ],
  "corrected_publication_numac": null
}

Credit advice verdict per customer and amount

AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon

The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Company registry (CBE) Crossroads Bank

Activities

Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Overige gespecialiseerde wetenschappelijke en technische activiteiten74909Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg74999

Primary activity highlighted.

Names & trade names

Legal nameNL

Xper Research

Registered office

Keirestraat 14

9700 Oudenaarde, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.

Similar companies Comparable size · 724 of 4,558 companies in this sector with filed accounts

ULRICK SMEYSTERS BE 0764.410.577 · Saint-Georges-sur-Meuse

GO4SAFETY BE 0644.996.055 · Tielt

MeiraGTx Belgium BE 0765.235.968 · Gent

VIGNY CONSULT BE 0755.476.679 · Ath

Rehubs Europe BE 1001.717.119 · Etterbeek